Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - A systematic review

Multiple Sclerosis Journal

Volumn 19, Issue 12, 2013, Pages 1556-1564

  Wens, Inez ^a   Dalgas, Ulrik ^b   Stenager, Egon ^c,d   Eijnde, Bert O ^a  

^a HASSELT UNIVERSITY   (Belgium)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Sonderborg Hospital   (Denmark)

Author keywords

body composition; Cardiovascular diseases; dyslipidemia; glucose intolerance; hypertension; metabolic syndrome; multiple sclerosis

Indexed keywords

BODY COMPOSITION; BODY MASS; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; META ANALYSIS; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR;

ADIPOSITY; BODY COMPOSITION; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; GLUCOSE INTOLERANCE; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; OBESITY; RISK FACTORS;

EID: 84885821596     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513504252     Document Type: Review

References (60)

1. Stuifbergen AK. Physical activity and perceived health status in persons with multiple sclerosis. J Neurosci Nurs. 1997 ; 29: 238-243
2. Ng AV, Kent-Braun JA. Quantitation of lower physical activity in persons with multiple sclerosis. Med Sci Sports Exerc. 1997 ; 29: 517-523
3. Motl RW, Arnett PA, Smith MM, et al. Worsening of symptoms is associated with lower physical activity levels in individuals with multiple sclerosis. Mult Scler. 2008 ; 14: 140-142
4. Pietilainen KH, Kaprio J, Borg P, et al. Physical inactivity and obesity: A vicious circle. Obesity (Silver Spring). 2008 ; 16: 409-414
5. Haapanen-Niemi N, Miilunpalo S, Pasanen M, et al. Body mass index, physical inactivity and low level of physical fitness as determinants of all-cause and cardiovascular disease mortality - 16 y follow-up of middle-aged and elderly men and women. Int J Obes Relat Metab Disord. 2000 ; 24: 1465-1474
6. Fogelholm M. Physical activity, fitness and fatness: Relations to mortality, morbidity and disease risk factors. A systematic review. Obes Rev. 2010 ; 11: 202-221
7. Prasad DS, Das BC. Physical inactivity: A cardiovascular risk factor. Indian J Med Sci. 2009 ; 63: 33-42
8. Arsenault BJ, Rana JS, Lemieux I, et al. Physical inactivity, abdominal obesity and risk of coronary heart disease in apparently healthy men and women. Int J Obes (Lond). 2010 ; 34: 340-347
9. Kokkinos P, Sheriff H, Kheirbek R. Physical inactivity and mortality risk. Cardiol Res Pract. 2011 ; 2011: 924945
10. Dubbert PM, Carithers T, Sumner AE, et al. Obesity, physical inactivity, and risk for cardiovascular disease. Am J Med Sci. 2002 ; 324: 116-126
11. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 ; 37: 1595-1607
12. Grundy SM, Hansen B, Smith SC, et al. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Arterioscler Thromb Vasc Biol. 2004 ; 24: e19 - e24
13. PhillipsBBallCSackettD. Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009) Online referencing, http://www.cebm.net/index. aspx?o=1025 (2009, accessed 1 August 2013).
14. Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain. 2004 ; 127: 844-850
15. Koch-Henriksen N, Bronnum-Hansen H, Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: Results from the Danish Multiple Sclerosis Registry. J Neurol Neurosurg Psychiatry. 1998 ; 65: 56-59
16. Kang JH, Chen YH, Lin HC. Comorbidities amongst patients with multiple sclerosis: A population-based controlled study. Eur J Neurol. 2010 ; 17: 1215-1219
17. Lavela SL, Prohaska TR, Furner S, et al. Chronic diseases in male veterans with multiple sclerosis. Prev Chronic Dis. 2012 ; 9: E55
18. Lalmohamed A, Bazelier MT, Van Staa TP, et al. Causes of death in patients with multiple sclerosis and matched referent subjects: A population-based cohort study. Eur J Neurol. 2012 ; 19: 1007-1014
19. Fleming ST, Blake J. Patterns of comorbidity in elderly patients with multiple sclerosis. J Clin Epidemiol. 1994 ; 47: 1127-1132
20. Allen NB, Lichtman JH, Cohen HW, et al. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology. 2008 ; 30: 234-238
21. Marrie RA, Cutter G, Tyry T. Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis. Multiple Sclerosis. 2011 ; 17: 1464-1471
22. Dallmeijer AJ, Beckerman H, de Groot V, et al. Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis. J Rehabil Med. 2009 ; 41: 322-326
23. Petajan JH, Gappmaier E, White AT, et al. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol. 1996 ; 39: 432-441
24. Formica CA, Cosman F, Nieves J, et al. Reduced bone mass and fat-free mass in women with multiple sclerosis: Effects of ambulatory status and glucocorticoid use. Calcif Tissue Int. 1997 ; 61: 129-133
25. Lambert CP, Lee AR, Evans WJ. Body composition in ambulatory women with multiple sclerosis. Arch Phys Med Rehabil. 2002 ; 83: 1559-1561
26. Slawta JN, McCubbin JA, Wilcox AR, et al. Coronary heart disease risk between active and inactive women with multiple sclerosis. Med Sci Sports Exerc. 2002 ; 34: 905-912
27. Slawta JN, Wilcox AR, McCubbin JA, et al. Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. Arch Phys Med Rehabil. 2003 ; 84: 1823-1830
28. White LJ, McCoy SC, Castellano V, et al. Effect of resistance training on risk of coronary artery disease in women with multiple sclerosis. Scand J Clin Lab Invest. 2006 ; 66: 351-355
29. Mojtahedi MC, Snook EM, Motl RW, et al. Bone health in ambulatory individuals with multiple sclerosis: Impact of physical activity, glucocorticoid use, and body composition. J Rehabil Res Dev. 2008 ; 45: 851-861
30. Khurana SR, Bamer AM, Turner AP, et al. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil. 2009 ; 88: 83-91
31. Sioka C, Fotopoulos A, Georgiou A, et al. Body composition in ambulatory patients with multiple sclerosis. J Clin Densitom. 2011 ; 14: 465-470
32. Mahler A, Steiniger J, Bock M, et al. Is metabolic flexibility altered in multiple sclerosis patients?. PLoS One. 2012 ; 7: e43675
33. Comoglu S, Yardimci S, Okcu Z. Body fat distribution and plasma lipid profiles of patients with multiple sclerosis. Turk J Med Sci. 2004 ; 34: 43-48
34. Snook EM, Mojtahedi MC, Evans EM, et al. Physical activity and body composition among ambulatory individuals with multiple sclerosis. Int J MS Care. 2005 ; 7: 137-142
35. Flegal KM, Carroll MD, Kuczmarski RJ, et al. Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998 ; 22: 39-47
36. Warren S, Warren KG. Multiple sclerosis and associated diseases: A relationship to diabetes mellitus. Can J Neurol Sci. 1981 ; 8: 35-39
37. Hussein WI, Reddy SS. Prevalence of diabetes in patients with multiple sclerosis. Diabetes care. 2006 ; 29: 1984-1985
38. Sternberg Z, Leung C, Sternberg D, et al. The prevalence of the classical and non-classical cardiovascular risk factors in multiple sclerosis patients. CNS Neurol Disord Drug Targets. 2013 ; 12: 104-111
39. Marrie R, Horwitz R, Cutter G, et al. Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler. 2008 ; 14: 1091-1098
40. Warren SA, Turpin KVL, Pohar SL, et al. Comorbidity and health-related quality of life in people with multiple sclerosis. Int J MS Care. 2009 ; 11: 6-16
41. Buchanan RJ, Schiffer R, Stuifbergen A, et al. Demographic and disease characteristics of people with multiple sclerosis living in urban and rural areas. Int J MS Care. 2006 ; 8: 89-97
42. Nuyen J, Schellevis FG, Satariano WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: A general practice-based controlled study. J Clin Epidemiol. 2006 ; 59: 1274-1284
43. Anema JR, Heijenbrok MW, Faes TJ, et al. Cardiovascular autonomic function in multiple sclerosis. J Neurol Sci. 1991 ; 104: 129-134
44. Pepin EB, Hicks RW, Spencer MK, et al. Pressor response to isometric exercise in patients with multiple sclerosis. Med Sci Sports Exerc. 1996 ; 28: 656-660
45. Sanya EO, Tutaj M, Brown CM, et al. Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients. Clin Auton Res. 2005 ; 15: 213-218
46. Sterman AB, Coyle PK, Panasci DJ, et al. Disseminated abnormalities of cardiovascular autonomic functions in multiple sclerosis. Neurology. 1985 ; 35: 1665-1668
47. Giubilei F, Antonini G, Di LS, et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand. 2002 ; 106: 109-112
48. Salemi G, Gueli MC, Vitale F, et al. Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. Lipids Health Dis. 2010 ; 9: 19
49. Okura Y, Urban LH, Mahoney DW, et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004 ; 57: 1096-1103
50. Marrie RA, Horwitz RI. Emerging effects of comorbidities on multiple sclerosis. Lancet Neurol. 2010 ; 9: 820-828
51. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: A longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler. 1999 ; 5: 349-354
52. Horton M, Rudick RA, Hara-Cleaver C, et al. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010 ; 35: 83-90
53. Pozzilli C, Marinelli F, Romano S, et al. Corticosteroids treatment. J Neurol Sci. 2004 ; 223: 47-51
54. Pagano G, Cavallo-Perin P, Cassader M, et al. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest. 1983 ; 72: 1814-1820
55. Yoon YS, Oh SW, Baik HW, et al. Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr. 2004 ; 80: 217-224
56. Carnethon MR, Loria CM, Hill JO, et al. Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care. 2004 ; 27: 2707-2715
57. Yoo S, Nicklas T, Baranowski T, et al. Comparison of dietary intakes associated with metabolic syndrome risk factors in young adults: The Bogalusa Heart Study. Am J Clin Nutr. 2004 ; 80: 841-848
58. Oh SW, Yoon YS, Lee ES, et al. Association between cigarette smoking and metabolic syndrome: The Korea National Health and Nutrition Examination Survey. Diabetes Care. 2005 ; 28: 2064-2066
59. Mullington JM, Haack M, Toth M, et al. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis. 2009 ; 51: 294-302
60. Smith RM, Adeney-Steel M, Fulcher G, et al. Symptom change with exercise is a temporary phenomenon for people with multiple sclerosis. Arch Phys Med Rehabil. 2006 ; 87: 723-727